DRIO (DarioHealth) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


DRIO DarioHealth Corp DRIO
62 GF Score
Price $6.06
GF Value $7.16
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DarioHealth Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

DarioHealth's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

DRIO vs BEAT, ONMD, VASO: Margin of Safety % (DCF FCF Based) Comparison

For the Health Information Services subindustry, DarioHealth's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DarioHealth Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where DarioHealth's Margin of Safety % (DCF FCF Based) falls into.


DRIO
62GF Score
DarioHealth Corp DRIO
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be undervalued. The current stock price of $6.06 is trading 15.4% below its estimated GF Value™ of $7.16. GuruFocus considers DarioHealth to be Modestly Undervalued.

Key valuation signals for DRIO:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $7.16 vs. price of $6.06 (15.4% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DarioHealth Business Description

Address 322 West 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
62GF Score

Get the complete analysis for DRIO

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.06
Price
$7.16
GF Value